High Intra-Tumor TGF-β2 Predicts Poor Survival in Pediatric Cancer of the Brainstem
March 13, 2023 08:00 ET
|
Oncotelic Therapeutics, Inc.
-The TGFβ1 and TGFβ3 isoforms are predictive --Validation of TGFβ2 as therapeutic target AGOURA HILLS, Calif., March 13, 2023 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC)...